An unusual complication of treatment with orlistat

Clinical Nephrology

Volumn 71, Issue 4, 2009, Pages 430-432

  Karamadoukis, L ^a   Shivashankar, G H ^b,c   Ludeman, L ^b   Williams, A J ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^c CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Acute renal failure; Diabetes; Enteric hyperoxaluria; Hypoglycemia; Insulin; Obesity; Orlistat; Oxalate crystals

Indexed keywords

BIPHASIC INSULIN; CREATININE; GLUCOSE; HEMOGLOBIN; TETRAHYDROLIPSTATIN;

ACIDOSIS; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ACUTE OXALATE NEPHROPATHY; AGED; ARTICLE; CALCIUM OXALATE STONE; CASE REPORT; CREATININE BLOOD LEVEL; CRYSTALLURIA; GLOMERULUS FILTRATION RATE; HEART ARREST; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPEROXALURIA; HYPOGLYCEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMOCHROMIC NORMOCYTIC ANEMIA; OBESITY; PHYSICAL EXAMINATION; RECURRENT DISEASE; URINALYSIS; VASCULAR FIBROSIS;

EID: 66649105221     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71430     Document Type: Article

References (17)

1. Chaplin AJ. Histopathological occurrence and characterisation of calcium oxalate: a review. J Clin Path. 1977; 30: 800-811.
2. Chen CL et al. Acute oxalate nephropathy after ingestion of star fruit. Am J Kid Dis. 2001; 37: 418-422.
3. Courtney AE et al. Rapidly progressive renal failure associated with successful pharmacotherapy for obesity. Nephrol Dial Transplant. 2006; 21: 796-798.
4. Daugirdas JT et al. Handbook of dialysis. 3rd edition. Baltimore: Lippincott, Williams & Wilkins; 2001, 1-734.
5. Ferraz RR et al. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion. Kidney Int. 2004; 66: 676-682.
6. Hill P et al. Rapidly progressive irreversible renal failure in patients with pancreatic insufficiency. Am J Kid Dis. 2003; 42: 842-845.
7. Holmes RP et al. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001; 59: 270-276.
8. Hoppe B, Leuman E. Diagnostic and therapeutic strategies in hyperoxaluria: a plea for early intervention. Nephrol Dial Transplant. 2004; 19: 39-42.
9. Karamadoukis L et al. Is there a link between calcium oxalate crystalluria, orlistat and acute tubular necrosis? Nephrol Dial Transplant. Advance access published February 13, 2008.
10. Keiran S et al. Ethylene glycol toxicity. Am J Kid Dis. 2005; 46: e31-e33.
11. Macaluso MP, Berg NO. Calcium oxalate crystals in kidneys in acute tubular nephrosis and other renal diseases with functional failure. Acta Pathologica Microbiologica Scandinavica. 1959; 46: 197-205.
12. Nakamoto Y et al. Irreversible tubulointerstitial nephropathy associated with prolonged, massive intake of vitamin C. Nephrol Dial Transplant. 1998; 13: 754-756.
13. OMIM #259900. Hyperoxaluria, primary, type 1.
14. Parmar MS. Recurrent hypoglycaemia in a diabetic patient as a result of unexpected renal failure. BMJ. 2004; 328: 883-884.
15. Singh A et al. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. Am J Kid Dis. 2007; 49: 153-157.
16. The Royal College of Physicians of London. Anti-obesity drugs - guidance on appropriate prescribing and management. 2003, p. 1-29.
17. Weinrauch L et al. Decreased insulin requirement in acute renal failure in diabetic nephropathy. Arch Intern Med. 1978; 138: 399-402.